Portrait of Fields, Cleo

Fields, Cleo

U.S. Representative LA-6 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
195
Buys / sells
93% / 7%
Last trade
Jul 10, 2026
Last filing
Jul 30, 2026

Latest disclosed trades

Latest 10 of 195
Ticker Type Traded
TSM Buy Jul 10, 2026
NVDA Buy Jun 26, 2026
GOOG Buy Jun 15, 2026
MSFT Buy Jun 11, 2026
QNT Buy Jun 4, 2026
AAPL Buy May 14, 2026
TSM Buy Apr 9, 2026
GOOG Buy Mar 16, 2026
MSFT Buy Mar 12, 2026
AAPL Buy Feb 12, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Fields, Cleo stock trade activity

FilingIQ has indexed 195 congressional stock trade disclosures for Fields, Cleo. The most recent disclosed transaction is dated Jul 10, 2026.

Across the full history, 182 purchases and 13 sales have been disclosed under the STOCK Act.

Top tickers traded by Fields, Cleo

Frequently asked

How many stock trades has Fields, Cleo disclosed?
FilingIQ tracks 195 Periodic Transaction Report disclosures for Fields, Cleo, with the most recent dated Jul 10, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Fields, Cleo a net buyer or net seller?
Across the disclosed trade history, 182 (93%) were purchases and 13 (7%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Fields, Cleo come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.